Induction therapy in kidney transplant recipients: Description of the practices according to the calendar period from the French multicentric DIVAT cohort-Reference-Cited by-同舟云学术

Induction therapy in kidney transplant recipients: Description of the practices according to the calendar period from the French multicentric DIVAT cohort

Published:2020-10-22 Issue:10 Volume:15 Page:e0240929
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Boucquemont Julie^ORCID,Foucher Yohann^ORCID,Masset Christophe,Legendre Christophe,Scemla Anne,Buron Fanny,Morelon Emmanuel,Garrigue Valérie,Pernin Vincent,Albano Laetitia,Sicard Antoine,Girerd Sophie,Ladrière Marc,Giral Magali,Dantal Jacques,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. The role of Thymoglobulin induction in kidney transplantation: an update;G Mourad;Clin Transpl,2012

2. Thymoglobulin and Its Use in Renal Transplantation: A Review;UM Thiyagarajan;AJN,2013

3. Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients;C Noel;J Am Soc Nephrol,2009

4. Rabbit Antithymocyte Globulin versus Basiliximab in Renal Transplantation;DC Brennan;N Engl J Med,2006

5. Interleukin 2 receptor antagonists for kidney transplant recipients;AC Webster;Cochrane Database Syst Rev,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of lymphocyte-depleting antibodies in specific populations of kidney transplant recipients: A systematic review and meta-analysis;Transplantation Reviews;2023-12

2. Standardized, risk-adapted induction therapy in kidney transplantation;Journal of Nephrology;2023-09-09

3. Pharmacogenomics of Old and New Immunosuppressive Drugs for Precision Medicine in Kidney Transplantation;Journal of Clinical Medicine;2023-07-03

4. Very Low Dose Anti-Thymocyte Globulins Versus Basiliximab in Non-Immunized Kidney Transplant Recipients;Transplant International;2023-02-03

5. The comparative efficacy and safety of basiliximab and antithymocyte globulin in deceased donor kidney transplantation: a multicenter cohort study;Kidney Research and Clinical Practice;2023-01-31